Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jacotot

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Transplantation|July 1, 1992
Prevalence of dyslipidemia in liver transplant recipientsD Mathe, R Adam, C Malmendier, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratioG De Pinieux, P Chariot, M Ammi-Saïd, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Lipid transport genes and their relation to the syndrome of insulin resistanceD J Galton, Q Zhang, E Cavallero, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndromeS Braschi, D Masson, G Rostoker, et al.
Free Radical Biology & Medicine|January 1, 1997
Oleic acid rich diet protects against the oxidative modification of high density lipoproteinR Solà, A E La Ville, J L Richard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particlesE Cavallero, F Brites, B Delfly, et al.
Therapeutic Drug Monitoring|August 1, 1993
Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin AA M Gardier, D Mathé, X Guédeney, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 4, 1999
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patientsF D Brites, E Cavallero, C de Geitere, et al.
Atherosclerosis|December 1, 1991
Lipoprotein particle analysis comparing simvastatin and fenofibrateJ M Bard, H J Parra, G Luc, et al.
Clinical Science (London, England : 1979)|December 24, 1997
Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemiaQ Zhang, E Cavallero, M M Hoffmann, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Transplantation|July 1, 1992
Prevalence of dyslipidemia in liver transplant recipientsD Mathe, R Adam, C Malmendier, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratioG De Pinieux, P Chariot, M Ammi-Saïd, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Lipid transport genes and their relation to the syndrome of insulin resistanceD J Galton, Q Zhang, E Cavallero, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndromeS Braschi, D Masson, G Rostoker, et al.
Free Radical Biology & Medicine|January 1, 1997
Oleic acid rich diet protects against the oxidative modification of high density lipoproteinR Solà, A E La Ville, J L Richard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1995
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particlesE Cavallero, F Brites, B Delfly, et al.
Therapeutic Drug Monitoring|August 1, 1993
Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin AA M Gardier, D Mathé, X Guédeney, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 4, 1999
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patientsF D Brites, E Cavallero, C de Geitere, et al.
Atherosclerosis|December 1, 1991
Lipoprotein particle analysis comparing simvastatin and fenofibrateJ M Bard, H J Parra, G Luc, et al.
Clinical Science (London, England : 1979)|December 24, 1997
Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemiaQ Zhang, E Cavallero, M M Hoffmann, et al.
Pageof 15